Standard of Excellence: The Future of Fabrication—From Art to Automation
Knocking Down the Bone Pile: The Business Case for Component Reclamation
Global Sourcing Spotlight: The Hidden Power of the Rep Network
Wistron Corporation announced that its Board of Directors convened a meeting and approved a series of capital expenditures and an additional capital injection to support its manufacturing and EMS operations.
The Board approved additional capital expenditures of NTD 1.7 billion, NTD 7.5 billion, USD 24.5 million, and USD 22.7 million for the Hsinchu, Kaohsiung, Vietnam, and Malaysia sites, respectively, for facility construction and improvements, as well as the procurement of machinery and equipment. The Board also approved an additional capital injection of USD 150 million into its wholly owned subsidiary, WisLab EMS Corporation, to support future expansion in California, U.S.
These investments reflect Wistron's continued focus on strengthening its global manufacturing footprint and supporting growth across its semiconductor and EMS-related businesses.
